{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:17:17Z","timestamp":1790997437264,"version":"4.1.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>In recent years, the role of macrophages as the primary cell type contributing to foam cell formation and atheroma plaque development has been widely acknowledged. However, it has been long recognized that diffuse intimal thickening (DIM), which precedes the formation of early fatty streaks in humans, primarily consists of lipid-loaded smooth muscle cells (SMCs) and their secreted proteoglycans. Recent studies have further supported the notion that SMCs constitute the majority of foam cells in advanced atherosclerotic plaques. Given that SMCs are a major component of the vascular wall, they serve as a significant source of microvesicles and exosomes, which have the potential to regulate the physiology of other vascular cells. Notably, more than half of the foam cells present in atherosclerotic lesions are of SMC origin. In this review, we describe several mechanisms underlying the formation of intimal foam-like cells in atherosclerotic plaques. Based on these mechanisms, we discuss novel therapeutic approaches that have been developed to regulate the generation of intimal foam-like cells. These innovative strategies hold promise for improving the management of atherosclerosis in the near future.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1381520","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:59:01Z","timestamp":1718585941000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis"],"prefix":"10.3389","volume":"11","author":[{"given":"M. T.","family":"La Chica Lho\u00ebst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Claudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benitez-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vilades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rotllan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Escol\u00e0-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Llorente-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"B3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.ATV.17.1.149","article-title":"Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB\/E receptor","volume":"17","author":"Olsson","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"12257","DOI":"10.1074\/JBC.270.20.12257","article-title":"Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans","volume":"270","author":"Paananen","year":"1995","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"18957","DOI":"10.1074\/JBC.274.27.18957","article-title":"CD44, A cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells","volume":"274","author":"Hurt-Camejo","year":"1999","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/S11883-023-01145-8\/FIGURES\/2","article-title":"The greatly under-represented role of smooth muscle cells in atherosclerosis","volume":"25","author":"Francis","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/ATVBAHA.119.312434","article-title":"Smooth muscle cells contribute the majority of foam cells in ApoE (apolipoprotein E)-deficient mouse atherosclerosis","volume":"39","author":"Wang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1161\/01.ATV.20.6.1572","article-title":"LDL receptor\u2013related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells","volume":"20","author":"Llorente-Cort\u00e9s","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/HQ0302.105367","article-title":"Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor\u2013related protein and LDL receptors","volume":"22","author":"Llorente-Cort\u00e9s","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.ATV.0000193618.32611.8B","article-title":"Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells","volume":"26","author":"Llorente-Cort\u00e9s","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13531","DOI":"10.1073\/PNAS.1735526100","article-title":"Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading","volume":"100","author":"Rong","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/CVR\/CVAB046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.120.046672","article-title":"Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis","volume":"142","author":"Alencar","year":"2020","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/S41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.121.058389","article-title":"Effects of coronary artery disease-associated variants on vascular smooth muscle cells","volume":"146","author":"Solomon","year":"2022","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/CIRCRESAHA.122.321586","article-title":"Genetic regulation of SMC gene expression and splicing predict causal CAD genes","volume":"132","author":"Aherrahrou","year":"2023","journal-title":"Circ Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/ATVBAHA.111.226670","article-title":"Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation","volume":"31","author":"Davis-Dusenbery","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634\/-\/DC1","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","article-title":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits","volume":"103","author":"Fukumoto","year":"2001","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8D","article-title":"Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway","volume":"98","author":"Son","year":"2006","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nm.4109","article-title":"Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective","volume":"22","author":"Cherepanova","year":"2016","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","article-title":"Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis","volume":"25","author":"Wirka","year":"2019","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"900358","DOI":"10.3389\/FGENE.2022.900358","article-title":"Revealing the critical regulators of modulated smooth muscle cells in atherosclerosis in mice","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/S12276-023-00937-X","article-title":"ANGPTL4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulation","volume":"55","author":"Cho","year":"2023","journal-title":"Exp Mol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"H402","DOI":"10.1152\/AJPHEART.00084.2018","article-title":"Klf4 has an unexpected protective role in perivascular cells within the microvasculature","volume":"315","author":"Haskins","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/NCB2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/NATURE08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1101\/GAD.1842409","article-title":"MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1160\/TH13-11-0905","article-title":"MiR-143\/145 deficiency protects against progression of atherosclerosis in Ldlr\u2212\/\u2212 mice","volume":"112","author":"Sala","year":"2014","journal-title":"Thromb Haemost"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1161\/STROKEAHA.110.597575","article-title":"A unique microRNA signature associated with plaque instability in humans","volume":"42","author":"Cipollone","year":"2011","journal-title":"Stroke"},{"key":"B36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/ATVBAHA.121.317018","article-title":"Plaque evaluation by ultrasound and transcriptomics reveals BCLAF1 as a regulator of smooth muscle cell lipid transdifferentiation in atherosclerosis","volume":"42","author":"Rykaczewska","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/01.ATV.19.6.1430","article-title":"Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway","volume":"19","author":"Neuville","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0008-6363(01)00274-7","article-title":"Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells","volume":"51","author":"Watanabe","year":"2001","journal-title":"Cardiovasc Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/J.BIOACTMAT.2022.01.012","article-title":"Matrix stiffness exacerbates the proinflammatory responses of vascular smooth muscle cell through the DDR1-DNMT1 mechanotransduction axis","volume":"17","author":"Wang","year":"2022","journal-title":"Bioact Mater"},{"key":"B40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/PHYSREV.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1073\/PNAS.92.14.6547","article-title":"T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role","volume":"92","author":"Peoples","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.15252\/EMMM.201506181","article-title":"Smooth muscle FGF\/TGF\u03b2 cross talk regulates atherosclerosis progression","volume":"8","author":"Chen","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17556","DOI":"10.1074\/JBC.M109.076414","article-title":"Notch and transforming growth factor-\u03b2 (TGF\u03b2) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation","volume":"285","author":"Tang","year":"2010","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.CCA.2014.12.007","article-title":"Interferon-\u03b3 in foam cell formation and progression of atherosclerosis","volume":"441","author":"Yu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/J.CYTO.2013.05.016","article-title":"Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis\u22c6","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2172-9-70","article-title":"Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells","volume":"9","author":"Persson","year":"2008","journal-title":"BMC Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"77","author":"Cagnina","year":"1999","journal-title":"Rev Med Liege"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension"},{"key":"B49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","article-title":"Hypertension and the pathogenesis of atherosclerosis","volume":"25","author":"Alexander","year":"1995","journal-title":"Hypertension"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF03085963\/METRICS","article-title":"Regulation and characteristics of vascular smooth muscle cell phenotypic diversity","volume":"15","author":"Rensen","year":"2007","journal-title":"Netherlands Hear J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/SJ.BJP.0701171","article-title":"The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration","volume":"121","author":"Nishio","year":"1997","journal-title":"Br J Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1006\/bbrc.2001.5232","article-title":"Reactive oxygen and NF-\u03baB in VEGF-induced migration of human vascular smooth muscle cells","volume":"285","author":"Wang","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1006\/BBRC.2001.5085","article-title":"Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells","volume":"284","author":"Ammarguellat","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1161\/01.RES.0000077044.60138.7C","article-title":"Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase\u2013derived reactive oxygen species","volume":"92","author":"Grote","year":"2003","journal-title":"Circ Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/BJ2880093","article-title":"Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation","volume":"288","author":"Southgate","year":"1992","journal-title":"Biochem J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/01.RES.85.12.1179","article-title":"Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery","volume":"85","author":"Mason","year":"1999","journal-title":"Circ Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","article-title":"Vascular NAD(P)H oxidases: specific features, expression, and regulation","volume":"285","author":"Lass\u00e8gue","year":"2003","journal-title":"Am J Physiol\u2014Regul Integr Comp Physiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1089\/ars.2013.5607","article-title":"NADPH Oxidases in vascular pathology","volume":"20","author":"Konior","year":"2014","journal-title":"Antioxidants Redox Signal"},{"key":"B59","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/ATVBAHA.108.181925","article-title":"Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation","volume":"29","author":"Lee","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/01.RES.0000221214.37803.79","article-title":"Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis","volume":"98","author":"Vendrov","year":"2006","journal-title":"Circ Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"26545","DOI":"10.1074\/JBC.M110.143917","article-title":"NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis","volume":"285","author":"Vendrov","year":"2010","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/J.ATHEROSCLEROSIS.2011.02.028","article-title":"Role for Nox1 NADPH oxidase in atherosclerosis","volume":"216","author":"Sheehan","year":"2011","journal-title":"Atherosclerosis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/J.FREERADBIOMED.2005.12.035","article-title":"Noxa1 is a central component of the smooth muscle NADPH oxidase in mice","volume":"41","author":"Ambasta","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.109.908319","article-title":"Nox activator 1","volume":"121","author":"Niu","year":"2010","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.redox.2018.11.021","article-title":"NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis","volume":"21","author":"Vendrov","year":"2019","journal-title":"Redox Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.ATV.0000251500.94478.18","article-title":"Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype","volume":"27","author":"Clempus","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.07.004","article-title":"Endothelial NADPH oxidase 4 protects ApoE\u2212\/\u2212 mice from atherosclerotic lesions","volume":"89","author":"Craige","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/J.FREERADBIOMED.2016.07.013","article-title":"NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis","volume":"97","author":"Di Marco","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1093\/EURHEARTJ\/EHV460","article-title":"The NADPH oxidase Nox4 has anti-atherosclerotic functions","volume":"36","author":"Sch\u00fcrmann","year":"2015","journal-title":"Eur Heart J"},{"key":"B70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/01.RES.71.1.218","article-title":"Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation","volume":"71","author":"Tertov","year":"1992","journal-title":"Circ Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0006-291X(89)92163-3","article-title":"Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins","volume":"163","author":"Tertov","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0021-9150(94)90010-8","article-title":"Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells","volume":"105","author":"Ehsan Ismail","year":"1994","journal-title":"Atherosclerosis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/EURHEARTJ\/EHY319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur Heart J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/ATVBAHA.120.314329","article-title":"Plant lipoprotein) stanol aggregation esters reduce by LDL altering (low-density LDL surface lipids","volume":"40","author":"Ruuth","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.ATHEROSCLEROSIS.2018.01.004","article-title":"PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions","volume":"269","author":"Hilvo","year":"2018","journal-title":"Atherosclerosis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1161\/ATVBAHA.120.315766","article-title":"Overfeeding saturated fat increases LDL (low-density lipoprotein) aggregation susceptibility while overfeeding unsaturated fat decreases proteoglycan-binding of lipoproteins","volume":"41","author":"Ruuth","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/J.JACL.2021.08.060","article-title":"Lipidomic changes of LDL after consumption of camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism\u2014a randomized controlled trial","volume":"15","author":"Erkkil\u00e4","year":"2021","journal-title":"J Clin Lipidol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.3390\/JCM10163571","article-title":"Apolipoprotein and LRP1-based peptides as new therapeutic tools in atherosclerosis","volume":"10","author":"Benitez-Amaro","year":"2021","journal-title":"J Clin Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1194\/JLR.M059485","article-title":"Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation","volume":"56","author":"Nguyen","year":"2015","journal-title":"J Lipid Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1096\/FJ.14-264036","article-title":"Clusterin\/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation","volume":"29","author":"Mart\u00ednez-Bujidos","year":"2015","journal-title":"FASEB J"},{"key":"B81","doi-asserted-by":"publisher","first-page":"158541","DOI":"10.1016\/J.BBALIP.2019.158541","article-title":"Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113\u2013122]apoJ","volume":"1865","author":"Rivas-Urbina","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/J.BBAMEM.2019.05.003","article-title":"Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation","volume":"1861","author":"Benitez-Amaro","year":"2019","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2000037","DOI":"10.1002\/ADTP.202000037","article-title":"Development of innovative antiatherosclerotic peptides through the combination of molecular modeling and a dual (biochemical-cellular) screening system","volume":"3","author":"Benitez-Amaro","year":"2020","journal-title":"Adv Ther"},{"key":"B84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/164_2020_364","article-title":"Smooth muscle cell-proteoglycan-lipoprotein interactions as drivers of atherosclerosis","volume":"270","author":"Allahverdian","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/J.FREERADBIOMED.2015.08.027","article-title":"Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice","volume":"89","author":"Delgado-Roche","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0021-9150(01)00714-6","article-title":"Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties","volume":"162","author":"Figueroa","year":"2002","journal-title":"Atherosclerosis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/S00018-004-3389-4","article-title":"Regulation of glycosaminoglycan structure and atherogenesis","volume":"61","author":"Ballinger","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/ATVBAHA.111.238659","article-title":"Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans","volume":"32","author":"Soto","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1161\/ATVBAHA.112.300444","article-title":"Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Brito","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.PHARMTHERA.2018.02.005","article-title":"Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: implications for lipoprotein binding and atherosclerosis","volume":"187","author":"Afroz","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B91","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.ATV.0000067937.93716.DB","article-title":"Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1172\/JCI2265","article-title":"Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding","volume":"101","author":"Bor\u00e9n","year":"1998","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/NATURE00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/JEM.20042309","article-title":"Identification of proteoglycans as the APRIL-specific binding partners","volume":"201","author":"Ingold","year":"2005","journal-title":"J Exp Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/S41586-021-03818-3","article-title":"APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans","volume":"597","author":"Tsiantoulas","year":"2021","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/S41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B97","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/J.EJPHAR.2009.09.066","article-title":"Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells","volume":"626","author":"Getachew","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/J.1582-4934.2009.00902.X","article-title":"Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo","volume":"14","author":"Ballinger","year":"2010","journal-title":"J Cell Mol Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/J.IMMUNI.2019.03.007","article-title":"Cytokine circuits in cardiovascular disease","volume":"50","author":"Williams","year":"2019","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1073\/PNAS.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/01.ATV.16.8.1074","article-title":"Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits","volume":"16","author":"Ameli","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/01.CIR.0000143162.56057.B5","article-title":"Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis","volume":"110","author":"Schiopu","year":"2004","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/J.JACC.2007.07.081","article-title":"Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(\u2212\/\u2212)\/low-density lipoprotein receptor(\u2212\/\u2212) mice","volume":"50","author":"Schiopu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/J.JACC.2011.07.017","article-title":"Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression","volume":"58","author":"Tsimikas","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/NBT1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat Biotechnol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/S12951-021-01047-4","article-title":"An atherosclerotic plaque-targeted single-chain antibody for MR\/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy","volume":"19","author":"Zhang","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0022-2275(20)31170-6","article-title":"Sequestration of aggregated LDL by macrophages studied with freeze-etch electron microscopy","volume":"42","author":"Haberland","year":"2001","journal-title":"J Lipid Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/ATVBAHA.109.191882","article-title":"Aggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization","volume":"29","author":"Grosheva","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1194\/JLR.M700039-JLR200","article-title":"Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages","volume":"48","author":"Llorente-Cort\u00e9s","year":"2007","journal-title":"J Lipid Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1074\/JBC.M115.638361","article-title":"K domain CR9 of low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells","volume":"290","author":"Costales","year":"2015","journal-title":"J Biol Chem"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.7150\/THNO.37305","article-title":"Immunization with the Gly1127-Cys1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies","volume":"10","author":"Bornachea","year":"2020","journal-title":"Theranostics"},{"key":"B112","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.ATHEROSCLEROSIS.2016.07.927","article-title":"The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells","volume":"252","author":"Dissmore","year":"2016","journal-title":"Atherosclerosis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"E166","DOI":"10.1161\/ATVBAHA.120.314350","article-title":"SLRP1 (soluble low-density lipoprotein receptor-related protein 1): a novel biomarker for P2Y12 (P2Y purinoceptor 12) receptor expression in atherosclerotic plaques","volume":"40","author":"Chen","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"E8499","DOI":"10.1073\/PNAS.1810724115\/SUPPL_FILE\/PNAS.1810724115.SAPP.PDF","article-title":"Macrophages release plasma membrane-derived particles rich in accessible cholesterol","volume":"115","author":"He","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e50231","DOI":"10.7554\/ELIFE.50231","article-title":"Release of cholesterol-rich particles from the macrophage plasma membrane during movement of filopodia and lamellipodia","volume":"8","author":"Hu","year":"2019","journal-title":"Elife"},{"key":"B116","doi-asserted-by":"publisher","first-page":"E354","DOI":"10.1161\/ATVBAHA.120.316063","article-title":"Low LAL (lysosomal acid lipase) expression by smooth muscle cells relative to macrophages as a mechanism for arterial foam cell formation","volume":"41","author":"Dubland","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"24020","DOI":"10.1074\/JBC.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J Biol Chem"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1194\/JLR.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J Lipid Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"10476","DOI":"10.1073\/PNAS.1922879117","article-title":"Cultured macrophages transfer surplus cholesterol into adjacent cells in the absence of serum or high-density lipoproteins","volume":"117","author":"He","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1161\/CIRCULATIONAHA.108.841130","article-title":"ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells","volume":"119","author":"Choi","year":"2009","journal-title":"Circulation"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e210022","DOI":"10.20900\/IMMUNOMETAB20210022","article-title":"Meta-analysis of smooth muscle lineage transcriptomes in atherosclerosis and their relationships to in vitro models","volume":"3","author":"Conklin","year":"2021","journal-title":"Immunometabolism"},{"key":"B122","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/ATVBAHA.114.304029\/-\/DC1","article-title":"Cholesterol loading reprograms the microRNA-143\/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype","volume":"35","author":"Vengrenyuk","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/JCDD10100416","article-title":"Dissecting the impact of vascular smooth muscle cell ABCA1 versus ABCG1 expression on cholesterol efflux and macrophage-like cell transdifferentiation: the role of SR-BI","volume":"10","author":"Oladosu","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5551\/JAT.32854","article-title":"Role of LCAT in atherosclerosis","volume":"23","author":"Ossoli","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"B125","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1124\/JPET.110.169540","article-title":"Effect of recombinant human lecithin-cholesterol:acyltransferase infusion on lipoprotein metabolism in mice","volume":"335","author":"Rousset","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"B126","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: first-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"J Clin Lipidol"}],"updated-by":[{"DOI":"10.3389\/fcvm.2026.1808883","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1381520\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:49:51Z","timestamp":1776707391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1381520\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":126,"alternative-id":["10.3389\/fcvm.2024.1381520"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1381520","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"article-number":"1381520"}}